These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 16426068)

  • 1. A two model receptor system of the alpha1D adrenergic receptor to describe interactions with epinephrine and BMY7378.
    Bautista DL; Morris DH; Stein L; Asher W; Hammitt T
    J Chem Inf Model; 2006; 46(1):334-44. PubMed ID: 16426068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two model system of the alpha1A-adrenoceptor docked with selected ligands.
    Asher WB; Hoskins SN; Slasor LA; Morris DH; Cook EM; Bautista DL
    J Chem Inf Model; 2007; 47(5):1906-12. PubMed ID: 17715910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The unique nature of the serine interactions for alpha 1-adrenergic receptor agonist binding and activation.
    Hwa J; Perez DM
    J Biol Chem; 1996 Mar; 271(11):6322-7. PubMed ID: 8626427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phe-308 and Phe-312 in transmembrane domain 7 are major sites of alpha 1-adrenergic receptor antagonist binding. Imidazoline agonists bind like antagonists.
    Waugh DJ; Gaivin RJ; Zuscik MJ; Gonzalez-Cabrera P; Ross SA; Yun J; Perez DM
    J Biol Chem; 2001 Jul; 276(27):25366-71. PubMed ID: 11331292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The activation process of the alpha1B-adrenergic receptor: potential role of protonation and hydrophobicity of a highly conserved aspartate.
    Scheer A; Fanelli F; Costa T; De Benedetti PG; Cotecchia S
    Proc Natl Acad Sci U S A; 1997 Feb; 94(3):808-13. PubMed ID: 9023338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling the interactions between alpha(1)-adrenergic receptors and their antagonists.
    Du L; Li M
    Curr Comput Aided Drug Des; 2010 Sep; 6(3):165-78. PubMed ID: 20412040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative molecular dynamics simulations of uncomplexed, 'agonist-bound' and 'antagonist-bound' alpha1A adrenoceptor models.
    Kinsella GK; Rozas I; Watson GW
    Biochem Biophys Res Commun; 2005 Aug; 333(3):737-41. PubMed ID: 15955528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-talk with β2 -adrenoceptors enhances ligand affinity properties from endothelial alpha1 D -adrenoceptors that mediates carotid relaxation.
    Pernomian L; Gomes MS; Restini CB; Pupo AS; de Oliveira AM
    J Pharm Pharmacol; 2013 Sep; 65(9):1337-46. PubMed ID: 23927472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanisms of ligand binding and activation in alpha 1-adrenergic receptors.
    Perez DM; Hwa J; Zhao MM; Porter J
    Adv Pharmacol; 1998; 42():398-403. PubMed ID: 9327924
    [No Abstract]   [Full Text] [Related]  

  • 10. Novel aromatic residues in transmembrane domains IV and V involved in agonist binding at alpha(1a)-adrenergic receptors.
    Waugh DJ; Zhao MM; Zuscik MJ; Perez DM
    J Biol Chem; 2000 Apr; 275(16):11698-705. PubMed ID: 10766790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ligand design for alpha(1) adrenoceptors.
    Bremner JB; Griffith R; Coban B
    Curr Med Chem; 2001 May; 8(6):607-20. PubMed ID: 11281844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Theoretical proton affinities of alpha1 adrenoceptor ligands.
    Kinsella GK; Watson GW; Rozas I
    Bioorg Med Chem; 2006 Mar; 14(5):1580-7. PubMed ID: 16256353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frontal analysis of cell-membrane chromatography for determination of drug-alpha(1D) adrenergic receptor affinity.
    Zeng A; Yuan B; Wang C; Yang G; He L
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jul; 877(20-21):1833-7. PubMed ID: 19493707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular exploration of the α(1A)-adrenoceptor orthosteric site: binding site definition for epinephrine, HEAT and prazosin.
    Maïga A; Dupont M; Blanchet G; Marcon E; Gilquin B; Servent D; Gilles N
    FEBS Lett; 2014 Dec; 588(24):4613-9. PubMed ID: 25447534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-fructose feeding impacts on the adrenergic control of renal haemodynamics in the rat.
    Abdulla MH; Sattar MA; Johns EJ; Abdullah NA; Hye Khan MA; Rathore HA
    Br J Nutr; 2012 Jan; 107(2):218-28. PubMed ID: 21733307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-dimensional models for agonist and antagonist complexes with beta 2 adrenergic receptor.
    Kontoyianni M; DeWeese C; Penzotti JE; Lybrand TP
    J Med Chem; 1996 Oct; 39(22):4406-20. PubMed ID: 8893835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computer simulations of signal transduction mechanism in alpha 1B-adrenergic and m3-muscarinic receptors.
    Fanelli F; Menziani MC; De Benedetti PG
    Protein Eng; 1995 Jun; 8(6):557-64. PubMed ID: 8532680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Site-directed mutagenesis of alpha 2A-adrenergic receptors: identification of amino acids involved in ligand binding and receptor activation by agonists.
    Wang CD; Buck MA; Fraser CM
    Mol Pharmacol; 1991 Aug; 40(2):168-79. PubMed ID: 1678850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-activity relationships in 1,4-benzodioxan-related compounds. 6. Role of the dioxane unit on selectivity for alpha(1)-adrenoreceptor subtypes.
    Quaglia W; Pigini M; Piergentili A; Giannella M; Marucci G; Poggesi E; Leonardi A; Melchiorre C
    J Med Chem; 1999 Jul; 42(15):2961-8. PubMed ID: 10425105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Theoretical evidence of a salt bridge disruption as the initiating process for the alpha1d-adrenergic receptor activation: a molecular dynamics and docking study.
    Carrieri A; Centeno NB; Rodrigo J; Sanz F; Carotti A
    Proteins; 2001 Jun; 43(4):382-94. PubMed ID: 11340655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.